Abstract
Antipsychotics are often the first line of treatment for individuals with schizophrenia (). One challenge to effective treatment is lack of adherence to prescribed medication. Lower rates of adherence are associated with considerably higher rates of relapse and poorer course of illness. Therefore studying the characteristics that may be related to medication adherence is important. Coping styles may be one such factor. Individuals use a variety of coping mechanisms to manage and navigate difficult life events, including mental illness (). In the present study, 40 individuals with schizophrenia were assessed regarding their coping styles and medication adherence practices. As hypothesized, it was found that denial coping was inversely related to medication adherence. However, contrary to expectations, acceptance coping was not related to medication adherence. These findings suggest that targeting denial coping strategies in treatment may help foster more optimal strategies for managing schizophrenia.
| Original language | English |
|---|---|
| Pages (from-to) | 580-584 |
| Number of pages | 5 |
| Journal | Journal of Nervous and Mental Disease |
| Volume | 197 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 1 2009 |
Fingerprint
Keywords
- Acceptance
- Coping
- Denial
- Medication adherence
- Schizophrenia
ASJC Scopus subject areas
- Psychiatry and Mental health
- Medicine(all)
Cite this
Denial and acceptance coping styles and medication adherence in schizophrenia. / Aldebot, Stephanie; Weisman, Amy G.
In: Journal of Nervous and Mental Disease, Vol. 197, No. 8, 01.08.2009, p. 580-584.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Denial and acceptance coping styles and medication adherence in schizophrenia
AU - Aldebot, Stephanie
AU - Weisman, Amy G
PY - 2009/8/1
Y1 - 2009/8/1
N2 - Antipsychotics are often the first line of treatment for individuals with schizophrenia (). One challenge to effective treatment is lack of adherence to prescribed medication. Lower rates of adherence are associated with considerably higher rates of relapse and poorer course of illness. Therefore studying the characteristics that may be related to medication adherence is important. Coping styles may be one such factor. Individuals use a variety of coping mechanisms to manage and navigate difficult life events, including mental illness (). In the present study, 40 individuals with schizophrenia were assessed regarding their coping styles and medication adherence practices. As hypothesized, it was found that denial coping was inversely related to medication adherence. However, contrary to expectations, acceptance coping was not related to medication adherence. These findings suggest that targeting denial coping strategies in treatment may help foster more optimal strategies for managing schizophrenia.
AB - Antipsychotics are often the first line of treatment for individuals with schizophrenia (). One challenge to effective treatment is lack of adherence to prescribed medication. Lower rates of adherence are associated with considerably higher rates of relapse and poorer course of illness. Therefore studying the characteristics that may be related to medication adherence is important. Coping styles may be one such factor. Individuals use a variety of coping mechanisms to manage and navigate difficult life events, including mental illness (). In the present study, 40 individuals with schizophrenia were assessed regarding their coping styles and medication adherence practices. As hypothesized, it was found that denial coping was inversely related to medication adherence. However, contrary to expectations, acceptance coping was not related to medication adherence. These findings suggest that targeting denial coping strategies in treatment may help foster more optimal strategies for managing schizophrenia.
KW - Acceptance
KW - Coping
KW - Denial
KW - Medication adherence
KW - Schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=68949149212&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=68949149212&partnerID=8YFLogxK
U2 - 10.1097/NMD.0b013e3181b05fbe
DO - 10.1097/NMD.0b013e3181b05fbe
M3 - Article
C2 - 19684494
AN - SCOPUS:68949149212
VL - 197
SP - 580
EP - 584
JO - Journal of Nervous and Mental Disease
JF - Journal of Nervous and Mental Disease
SN - 0022-3018
IS - 8
ER -